Latest Licensing News

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

Agrimin Limited has decided to withdraw from its Mackay Potash Project after a strategic review highlighted challenging market conditions and prohibitive holding costs. The company will now focus on other mineral opportunities in Western Australia.

Jupiter Energy reported steady oil sales of US$1.65 million in Q3 2025, all through domestic channels, while nearing completion of a key gas pipeline integration that promises operational efficiencies.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Ballard Mining’s September quarter report highlights promising drilling results at its Mt Ida Gold Project and secures final approvals for a 2.0 Mtpa processing plant, underpinning its development ambitions.

Weebit Nano has reported a fourfold revenue increase in FY25, driven by a landmark licensing agreement with semiconductor giant onsemi and key automotive-grade qualification for its ReRAM technology.

Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.

MyState Limited’s merger with Auswide Bank has driven a 17% rise in underlying net profit to $41.3 million for FY25, alongside a strengthened capital position and a fully franked 11 cent dividend.

Victory Metals reports substantial grade increases in terbium, dysprosium, and scandium at its North Stanmore Project, leveraging a simple beneficiation method that enhances strategic supply prospects amid tightening Chinese export controls.

Neurizon Therapeutics has been granted a key Australian patent for its lead drug candidate NUZ-001, extending protection for treatments targeting ALS, Alzheimer's, and other neurodegenerative diseases through 2041. This milestone complements earlier US patent grants and sets the stage for upcoming clinical trials.

Aurelia Metals reports a 12% increase in Mineral Resources and a 17% rise in Ore Reserves, driven by strong copper growth at its Peak Operation and the commencement of production at Federation Mine.

Sunrise Energy Metals has announced a significant 87% increase in the Ore Reserve Estimate for its Syerston Scandium Project, underpinning a 32-year mine life with steady scandium oxide production. The update comes amid tightening Chinese export controls, positioning the project as a critical non-Chinese scandium supply source.